SEL-73

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSEL-73
Drug Alias NameSEL-73
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor modulatorsSerotonin 7 (5-HT7) receptor modulatorsDopamine D2 receptor modulators +[5] 
TargetsSerotonin 7 (5-HT7) receptorSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor +[5] 
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRyvu Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRyvu Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A